Abdominal obesity and metabolic syndrome
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance or full-blown diabetes, and increased risk of developing cardiovascular disease. Proposed criteria for identifying patients with metabolic syndrome have contributed greatly to preventive medicine, but the value of metabolic syndrome as a scientific concept remains controversial. The presence of metabolic syndrome alone cannot predict global cardiovascular disease risk. But abdominal obesity - the most prevalent manifestation of metabolic syndrome - is a marker of 'dysfunctional adipose tissue', and is of central importance in clinical diagnosis. Better risk assessment algorithms are needed to quantify diabetes and cardiovascular disease risk on a global scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is strongly linked to visceral fat accumulation around abdominal organs, disrupting normal endocrine functions more than subcutaneous fat (Dam et al., 2016; Després & Lemieux, 2006).”
From Long-term cardiometabolic effects of early institutionalization and foster care: Evidence from the Bucharest Early Intervention Project (2026) · cites this paper as Després & Lemieux, 2006
In the citing paper
“Alarmingly, obesity is known to pose a more substantial health hazard than the other CMD risks [19,20,21].”
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [691]
In the citing paper
“The results of the present study contradict the prevailing dogma that VAT has deleterious metabolic effects (5,6).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [6]
In the citing paper
“The metabolic syndrome is a cluster of coronary heart disease risk factors-central obesity, hypertension, dyslipidemia, and glucose intolerance-that share an association with insulin resistance, which appears to be the primary underlying pathophysiologic disturbance (1).”
From Eating Meals Irregularly: A Novel Environmental Risk Factor for the Metabolic Syndrome (2008) · cites this paper as [1]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In obesity, there is evidence of macrophage infiltration in adipose tissu”
BackgroundPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“It has also been argued that current risk-assessment algorithms such as the Framingham Heart Study calculator of coronary heart disease (CHD) ris”
MethodThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Research works printed but not linked: 3
- Lemieux, I. et al. Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men. Obes. Res. 9, 66S (2001).
- Beckley, E. T. New ADA initiative moves beyond 'metabolic syndrome'. 'Cardiometabolic risk' proposed as umbrella term for diabetes risk factors. DOC News 3, 1–3 (2006).
- Després, J. P. From CVD risk to cardiometabolic risk. Presented at the Symposium of the International Chair on Cardiometabolic Risk. XIV International Symposium on Atherosclerosis (Rome, 18–22 June 2006).
Cited by
Items 501–600 of 1,035
Corona, G., Forti, G., & Maggi, M. (2008) · The Aging Male · doi:10.1080/13685530802468497 · Cited by 107
“The concept of MetS was later on introduced as a nosographic entity by Reaven in 1988 [4] to identify subjects with an higher risk of metabolic and CV diseases, but its utility in clinical practice is still a matter of active debate [1,5,6].”
BackgroundKokubo, Y., Okamura, T., Yoshimasa, Y., Miyamoto, Y., Kawanishi, K., Kotani, Y., Okayama, A., & Tomoike, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.2027 · Cited by 107
“Abdominal obesity induces inflammation in adiposities (23), endothelial dysfunction (24, 25), and oxidative stress (26), thereby contributing to CVD development (27, 28).”
BackgroundYao, D., Chang, Q., Wu, Q.-J., Gao, S.-Y., Zhao, H., Liu, Y.-S., Jiang, Y.-T., & Zhao, Y.-H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6303820 · Cited by 106
“Proposed mechanisms underlying the pathological association between VAT and IR include free fatty acid release into the hepatic portal circulation [46, 47].”
Models and mechanisms for hippocampal dysfunction in obesity and diabetes
Stranahan, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.045 · Cited by 103
“Increases in visceral white adipose tissue (vWAT) contribute to the detrimental effects of obesity on glycemic control (Després and Lemieux, 2006), while subcutaneous white adipose tissue (scWAT) represents both an active buffer and a protective metabolic ‘sink’ for energy storage outside of the…”
BackgroundPharmaceutically controlled designer circuit for the treatment of the metabolic syndrome
Ye, H., Hamri, G. C., Zwicky, K., Christen, M., Folcher, M., & Fussenegger, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216801110 · Cited by 113
“Eur J Cardiovasc Prev Rehabil 14(3):456–462.”
Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women
Michaud, A., Drolet, R., Noël, S., Paris, G., & Tchernof, A. (2011) · Metabolism · doi:10.1016/j.metabol.2011.10.004 · Cited by 117
“This is consistent with the notion that visceral obesity is a marker of dysfunctional adipose tissue [29].”
BackgroundEscobar-Morreale, H. F., Alvarez-Blasco, F., Botella-Carretero, J. I., & Luque-Ramirez, M. (2014) · Human Reproduction · doi:10.1093/humrep/deu198 · Cited by 103
“liver, muscle, heart or the intraperitoneal area) in the form of a dysfunctional adipose tissue (Despres and Lemieux, 2006).”
BackgroundInfluentialShort sleep duration as a risk factor for the development of the metabolic syndrome in adults
Chaput, J.-P., McNeil, J., Després, J.-P., Bouchard, C., & Tremblay, A. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.09.022 · Cited by 105
“The metabolic syndrome represents a cluster of cardiometabolic risk factors and is an important public health concern (Després and Lemieux, 2006).”
BackgroundSelf-citationIGF-1 and Its Receptor in Esophageal Cancer: Association with Adenocarcinoma and Visceral Obesity
Doyle, S. L., Donohoe, C. L., Finn, S. P., Howard, J. M., Lithander, F. E., Reynolds, J. V., Pidgeon, G. P., & Lysaght, J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.417 · Cited by 106
“Compared with subcutaneous adipose tissue, visceral adipose tissue is more metabolically active, secreting a number of adipokines and cytokines, leading to a proinflammatory, procoagulant and insulin resistant state, collectively known as the metabolic syndrome (”
BackgroundTona, F., Serra, R., Ascenzo, L. D., Osto, E., Scarda, A., Fabris, R., Montisci, R., Famoso, G., Tellatin, S., Foletto, M., et al. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.09.021 · Cited by 109
“Consistently, elevated levels of these cytokines have been shown in individuals with insulin resistance and diabetes [6,23,24].”
BackgroundRothney, M. P., Catapano, A. L., Xia, J., Wacker, W. K., Tidone, C., Grigore, L., Xia, Y., & Ergun, D. L. (2013) · Obesity · doi:10.1002/oby.20223 · Cited by 109
Pecorelli, N., Capretti, G. L., Sandini, M., Damascelli, A., Cristel, G., COBELLI, F. D., Gianotti, L. V., Zerbi, A., & Braga, M. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6216-5 · Cited by 109
Cytokines and inflammation in adipogenesis: an updated review
Jiang, N., Yao, L., Shu, T., & Wang, J. (2019) · Frontiers of Medicine · doi:10.1007/s11684-018-0625-0 · Cited by 114
Daud, N. M., Ismail, N. A., Thomas, E. L., Fitzpatrick, J. A., Bell, J. D., Swann, J. R., Costabile, A., Childs, C. E., Pedersen, C., Goldstone, A. P., et al. (2014) · Obesity · doi:10.1002/oby.20754 · Cited by 99
“This is of interest as increased visceral AT and liver fat accumulation have been associated with metabolic disturbances, including insulin resistance, hypertension and diabetes independent of BW (16,17).”
BackgroundUpright water-based exercise to improve cardiovascular and metabolic health: A qualitative review
Meredith-Jones, K. A., Waters, D. L., Legge, M., & Jones, L. M. (2011) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2011.02.002 · Cited by 128
Arteriolar Function in Visceral Adipose Tissue Is Impaired in Human Obesity
Farb, M. G., Ganley-Leal, L., Mott, M., Liang, Y., Ercan, B., Widlansky, M. E., Bigornia, S. J., Fiscale, A. J., Apovian, C. M., Carmine, B., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.235846 · Cited by 104
Chen, F., Wang, Y., Shan, X., Cheng, H., Hou, D., Zhao, X., Wang, T., Zhao, D., & Mi, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047380 · Cited by 119
“The concept of MetS in children and its clinical use remain controversial, and more future research is greatly needed [2,25].”
BackgroundFisher, G., Hyatt, T. C., Hunter, G. R., Oster, R. A., Desmond, R. A., & Gower, B. A. (2011) · Obesity · doi:10.1038/oby.2010.310 · Cited by 103
“It is believed when the subcutaneous fat depot becomes overwhelmed there is greater accumulation of visceral fat, which is associated with cardiovascular disease (13), the metabolic syndrome (14), and circulating levels of IL-6, TNF-α, and CRP (13,15).”
BackgroundThe Roles of the Secreted Phospholipase A2 Gene Family in Immunology
Murakami, M., Yamamoto, K., Miki, Y., Murase, R., Sato, H., & Taketomi, Y. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.05.001 · Cited by 110
“The incidence of metabolic syndrome has been increasing at an explosive rate worldwide due to a pandemic of obesity and type 2 diabetes resulting from overeating of high-caloric foods (Despres & Lemieux, 2006) .”
Donado-Pestana, C. M., Moura, M. H. C., de Araujo, R. L., Santiago, G. D. L., Barros, H. R. D. M., & Genovese, M. I. (2018) · Current Opinion in Food Science · doi:10.1016/j.cofs.2018.01.001 · Cited by 103
Omega-3 fatty acids and adipose tissue biology
Kuda, O., Rossmeisl, M., & Kopecky, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.004 · Cited by 100
Barrett Esophagus: Prevalence of Central Adiposity, Metabolic Syndrome, and a Proinflammatory State
Ryan, A. M., Healy, L., Power, D. G., Byrne, M., Murphy, S., Byrne, P. J., Kelleher, D. P., & Reynolds, J. V. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181612cac · Cited by 110
“This may be manifest in the metabolic syndrome, best described in association with cardiovascular disease and type 2 diabetes, where the usual screening variables are waist circumference, circulating levels of triacylglycerols and high-density lipoprotein cholesterol, fasting glycemia, and blood pressure.(9,10) It is…”
BackgroundVisceral adiposity as a target for the management of the metabolic syndrome
Kishida, K., Funahashi, T., Matsuzawa, Y., & Shimomura, I. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.564202 · Cited by 111
Heritability of metabolic syndrome traits in a large population-based sample
van Dongen, J., Willemsen, G., Chen, W.-M., de Geus, E. J. C., & Boomsma, D. I. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p041673 · Cited by 94
Bozorgmanesh, M., Hadaegh, F., & Azizi, F. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-88 · Cited by 113
“With the introduction of the MetS, the abdominal obesity was recognized as a clinically measurable (although imperfect) entity [35,41-43].”
BackgroundLagathu, C., Christodoulides, C., Tan, C. Y., Virtue, S., Laudes, M., Campbell, M., Ishikawa, K., Ortega, F. J., Tinahones, F. J., Fernández‐Real, J. M., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.107 · Cited by 117
“In this regard the ability of adipose tissue to expand and match the storage needs of energy surplus may be a key determinant of the susceptibility to developing Metabolic Syndrome associated with obesity (1-4).”
BackgroundInfluentialInteractions between adipose tissue and the immune system in health and malnutrition
Wensveen, F. M., Marinović, S., Šestan, M., Wensveen, T. T., & Polić, B. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.006 · Cited by 110
Pagé, A., Dumesnil, J. G., Clavel, M.-A., Chan, K. L., Teo, K. K., Tam, J. W., Mathieu, P., Després, J.-P., & Pibarot, P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.083 · Cited by 102
“Pibarot holds the Canada Research Chair 2 ipidemia, and proinflammatory state (1).”
BackgroundSelf-citationHajian‐Tilaki, K., Heidari, B., Firouzjahi, A., Bagherzadeh, M., Hajian-Tilaki, A., & Halalkhor, S. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.012 · Cited by 109
Queipo‐Ortuño, M. I., Escoté, X., Ceperuelo‐Mallafré, V., Garrido‐Sánchez, L., Miranda, M., Clemente‐Postigo, M., Pérez‐Pérez, R., Peral, B., Cardona, F., Fernández‐Real, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048605 · Cited by 102
“On the other hand, metabolic and functional differences between adipose tissue depots (subcutaneous (SAT) and visceral (VAT)) may be determinant in the development of obesity and related disorders [20,21].”
BackgroundBrindley, D. N., Kok, B. P., Kienesberger, P. C., Lehner, R. S., & Dyck, J. R. B. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00509.2009 · Cited by 111
“TG accumulation in myocytes and epicardial adipose tissue is highly correlated with the development and severity of insulin resistance and cardiovascular disease (38, 91).”
BackgroundLi, Q., Liu, F., Liu, J., Liao, S., & Zou, Y. (2019) · Nutrients · doi:10.3390/nu11051017 · Cited by 107
“Obesity affects body appearance and induces a variety of chronic diseases [2].”
BackgroundZhu, Y., Gui, W., Lin, X., & Li, H. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111753 · Cited by 106
Metabolic Syndrome: From the Genetics to the Pathophysiology
Sookoian, S., & Pirola, C. J. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0164-9 · Cited by 116
“Although the concept of the metabolic syndrome (MS)— also known as syndrome X, insulin resistance syndrome, and recently, cardiometabolic syndrome—may be considered as clinically irrelevant [1, 2], the MS is recognized as a major and prevalent cardiovascular risk factor [3–5].”
BackgroundLitwin, S. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.017 · Cited by 122
He, F., Bixler, E. O., Liao, J., Berg, A. S., Kawasawa, Y. I., Fernández‐Mendoza, J., Vgontzas, A. N., & Liao, D. (2015) · Sleep Medicine · doi:10.1016/j.sleep.2015.07.028 · Cited by 109
“Previous literature has also demonstrated associations between childhood obesity and increased risk of metabolic alterations and disease, such as insulin resistance, dyslipidemia, and metabolic syndrome [3,4].”
BackgroundScott, W. R., & Batterham, R. L. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00038.2011 · Cited by 100
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, E., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 97
Cordero-Herrera, I., Kozyra, M., Zhuge, Z., McCann Haworth, S., Moretti, C., Peleli, M., Caldeira-Dias, M., Jahandideh, A., Huirong, H., Cruz, J. D. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809406115 · Cited by 97
Determinants of Whole-Body Protein Metabolism in Subjects With and Without Type 2 Diabetes
Gougeon, R., Morais, J. A., Chevalier, S., Pereira, S., Lamarche, M., & Marliss, E. B. (2008) · Diabetes Care · doi:10.2337/dc07-1268 · Cited by 97
Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study
Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Skoumas, I., & Stefanadis, C. (2008) · Vascular Medicine · doi:10.1177/1358863x07087731 · Cited by 97
Sandforth, A., von Schwartzenberg, R. J., Arreola, E. V., Hanson, R. L., Sancar, G., Katzenstein, S., Lange, K., Preißl, H., Dreher, S. I., Weigert, C., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00235-8 · Cited by 100
Obesity and the metabolic syndrome in the elderly–a mini-review
Lechleitner, M. (2008) · Gerontology · doi:10.1159/000161734 · Cited by 100
“(table 1 ). Recommendations to measure waist circumference rather than the body mass index (BMI) support the central importance of abdominal obesity in the metabolic syndrome [”
BackgroundReil (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s5207 · Cited by 103
Iwase, T., Sangai, T., Nagashima, T., Sakakibara, M., Sakakibara, J., Hayama, S., Ishigami, E., Masuda, T., & Miyazaki, M. (2015) · Cancer Medicine · doi:10.1002/cam4.571 · Cited by 105
“In particular, visceral fat, which is more hormonally active than other types of body fat, strongly promotes these effects [6, 31].”
BackgroundElucidating the Preadipocyte and Its Role in Adipocyte Formation: a Comprehensive Review
Sarantopoulos, C. N., Banyard, D. A., Ziegler, M. E., Sun, B. J., Shaterian, A., & Widgerow, A. D. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9774-9 · Cited by 113
Estrada, S., Lu, R., Conjeti, S., Orozco‐Ruiz, X., Panos‐Willuhn, J., Breteler, M. M. B., & Reuter, M. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28022 · Cited by 102
“Recently, several studies have indicated a stronger relation between the accumulation of VATwith an adversemetabolic and inflammatory profile compared to SAT [8, 9].”
ResultAdipocyte Metabolism and Health after the Menopause: The Role of Exercise
Marsh, M. L., Oliveira, M. N., & Vieira‐Potter, V. J. (2023) · Nutrients · doi:10.3390/nu15020444 · Cited by 110
Pisto, P., Santaniemi, M., Bloigu, R., Ukkola, O., & Kesäniemi, Y. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004973 · Cited by 97
“In individuals with visceral obesity, insulin resistance may contribute to impaired non-esterified fatty acid (NEFA) metabolism(8) and the increasing NEFA flux to the liver may impair liver metabolism leading to increased glucose metabolism and liver dysfunction.(7) The liver is one of the targets of the resulting sys…”
BackgroundInfluentialMolière, S., Jaulin, A., Tomasetto, C.-L., & Dali-Youcef, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310649 · Cited by 92
“Accumulating evidence demonstrated that in conditions of excessive calorie consumption, the development of metabolic syndrome may be due to the absence or dysfunctional subcutaneous fat with states of insulin resistance, and the energy surplus will accumulate in visceral white adipose tissue (gonadal, perirenal, epica…”
BackgroundMetabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
Sidiropoulos, P. I., Karvounaris, S. A., & Boumpas, D. T. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2397 · Cited by 100
“produced in excess flux to the liver where they may impair liver metabolism (liver insulin resistance); more specifically, they increase hepatic glucose production (contributing to hyperglycemia), decrease apolipoprotein B degradation, and increase triacylglycerol-rich lipoproteins [ 20 ].”
BackgroundGheller, B. J. F., Riddle, E. S., Lem, M. R., & Thalacker-Mercer, A. E. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050901 · Cited by 98
Sánchez, J., Palou, A., & Picó, C. (2009) · Endocrinology · doi:10.1210/en.2009-0466 · Cited by 98
“White adipose tissue (WAT) plays a crucial role acting as a reservoir for fuel storage in the form of triacylglycerides (TGs) when there is a surplus of energy from the diet (6), but above certain thresholds, adiposity (particularly excess visceral fat accumulation) is related to the features of insulin resistance (4).”
BackgroundPedersen, L. R., Olsen, R. H., Anholm, C., Astrup, A., Eugen-Olsen, J., Fenger, M., Simonsen, L., Walzem, R. L., Haugaard, S. B., & Prescott, E. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0934-x · Cited by 98
Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals
Greco, M., Chiefari, E., Montalcini, T., Accattato, F., Costanzo, F. S., Pujia, A., Foti, D., Brunetti, A., & Gulletta, E. (2014) · Mediators of Inflammation · doi:10.1155/2014/750860 · Cited by 98
The role of adipokines in cardiovascular disease
Shibata, R., Ouchi, N., Ohashi, K., & Murohara, T. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.02.006 · Cited by 110
CREBH Regulates Systemic Glucose and Lipid Metabolism
Nakagawa, Y., & Shimano, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051396 · Cited by 103
Smoking and Endothelial Dysfunction
Golbidi, S., Edvinsson, L. I., & Laher, I. (2018) · Current Vascular Pharmacology · doi:10.2174/1573403x14666180913120015 · Cited by 107
Sleep Apnea and Sleep Habits: Relationships with Metabolic Syndrome
Borel, A. (2019) · Nutrients · doi:10.3390/nu11112628 · Cited by 105
“Excess visceral adipose tissue is believed to be a primary driver of the cardiometabolic complications of metabolic syndrome [3].”
BackgroundInfluentialYang, Y., Li, S., Ren, Q., Qiu, Y., Pan, M., Liu, G., Zheng, R., An, Z., & Li, S. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02518-2 · Cited by 104
“Visceral fat accumulation is considered a major risk factor for CVD, as it impairs vascular endothelial function through multiple pathways, including the release of pro-inflammatory cytokines and oxidative stress, thereby significantly increasing CVD risk [37, 38].”
Romeo, S., Vidal‐Puig, A., Husain, M., Ahima, R. S., Arca, M., Bhatt, D. L., Diehl, A. M., Fontana, L., Foo, R., Frühbeck, G., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf314 · Cited by 109
“7,9 Lipotoxicity initiates a heterogeneous, organ-specific, fibro-inflammatory response, shaping each person’s unique phenotype.”
Sphingolipid Content of Human Adipose Tissue: Relationship to Adiponectin and Insulin Resistance
Blachnio‐Zabielska, A. U., Koutsari, C., Tchkonia, T., & Jensen, M. D. (2012) · Obesity · doi:10.1038/oby.2012.126 · Cited by 96
“Upper body/abdominal obesity is a risk factor for insulin resistance, type two diabetes and metabolic syndrome (1,2).”
BackgroundMetabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat
Sheludiakova, A., Rooney, K. B., & Boakes, R. A. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0228-x · Cited by 104
“The glucose drink increased subcutaneous fat only, which is known to be considerably less metabolically active and less harmful to health [35].”
BackgroundKhan, N. A., Baym, C. L., Monti, J. M., Raine, L. B., Drollette, E. S., Scudder, M. R., Moore, R. D., Kramer, A. F., Hillman, C. H., & Cohen, N. J. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.10.008 · Cited by 106
“VAT, relative to SAAT, has been shown to be particularly pathogenic owing to its higher lipolytic activity and closer proximity to hepatic portal vasculature.(31) Thus, the finding that VAT did not predict memory performance after adjustment for covariates was surprising.”
Pérez‐Pérez, R., Ortega, F. J., García‐Santos, E., López, J. A., Camafeita, E., Ricart, W., Fernández‐Real, J. M., & Peral, B. (2009) · Journal of Proteome Research · doi:10.1021/pr800942k · Cited by 106
Clinical significance of visceral adiposity assessed by computed tomography: A Japanese perspective
Ryo, M., Kishida, K., Nakamura, T., Yoshizumi, T., Funahashi, T., & Shimomura, I. (2014) · World Journal of Radiology · doi:10.4329/wjr.v6.i7.409 · Cited by 105
Walsh, M., Cartwright, L., Corish, C., Sugrue, S., & Wood-Martin, R. (2011) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.21.5.365 · Cited by 69
“Third, body-composition analysis in this study did not differentiate between visceral and peripheral body fat— an important factor for assessing an individual’s future health risks (Després & Lemieux, 2006).”
BackgroundBodenant, M., Kuulasmaa, K., Wagner, A., Kee, F., Palmieri, L., Ferrario, M. M., Montaye, M., Amouyel, P., & Dallongeville, J. (2011) · Stroke · doi:10.1161/strokeaha.111.614099 · Cited by 93
“12 At inclusion, each MORGAM member (1) completed a questionnaire about demographic information, socioeconomic factors (educational level), lifestyle habits (tobacco and alcohol consumption), vascular risk factors (self-reported diabetes, serum total and high-density lipoprotein cholesterol), and medication use; (2) h…”
MethodMagkos, F., Fabbrini, E., Mohammed, B. S., Patterson, B. W., & Klein, S. (2010) · Obesity · doi:10.1038/oby.2010.90 · Cited by 95
Selvaraj, S., Martinez, E. E., Aguilar, F. G., Kim, K.-Y. A., Peng, J., Sha, J., Irvin, M. R., Lewis, C. E., Hunt, S. C., Arnett, D. K., et al. (2016) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.115.004396 · Cited by 92
Hege, A., Lemke, M. K., Apostolopoulos, Y., & Sönmez, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207322 · Cited by 110
Kahn, D., Macias, E., Zarini, S., Garfield, A., Zemski Berry, K., MacLean, P., Gerszten, R. E., Libby, A., Solt, C., Schoen, J., et al. (2022) · Endocrinology · doi:10.1210/endocr/bqac140 · Cited by 97
The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology
Després, J.-P., Cartier, A., Côté, M., & Arsenault, B. J. (2008) · Annals of Medicine · doi:10.1080/07853890802004959 · Cited by 93
“These results are consistent with the notion that the hyperglycemic state of the diabetic patient or the dysglycemic state of the prediabetic patient may only represent the tip of a large atherothrombotic inflammatory iceberg most frequently found among patients with abdominal obesity and with excess visceral/ectopic…”
ResultSelf-citationDiabetes and Metabolic Syndrome in Survivors of Childhood Cancer
Friedman, D. N., Tonorezos, E. S., & Cohen, P. (2019) · Hormone Research in Paediatrics · doi:10.1159/000495698 · Cited by 105
Ceramide metabolism is affected by obesity and diabetes in human adipose tissue
Błachnio-Zabielska, A. U., Pulka, M., Baranowski, M., Nikołajuk, A., Zabielski, P., Górska, M., & Górski, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22745 · Cited by 97
“Epidemiological studies have shown that the relationship between obesity and components of the metabolic syndrome are stronger for abdominal obesity than lower body obesity (Lapidus et al., 1994; Despres and Lemieux, 2006).”
BackgroundCederberg, H., Stančáková, A., Kuusisto, J., Laakso, M., & Smith, U. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12289 · Cited by 108
Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners?
van Laar, A., Grootaert, C., & Camp, J. V. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1743966 · Cited by 105
Zhang, Z.-Q., Deng, J., Li-ping, H., Ling, W., Su, Y., & Chen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070893 · Cited by 108
“The high metabolic and inflammatory activity of visceral fat deposits within the abdominal cavity, compared with subcutaneous deposits in other parts of the body, provide a plausible explanation for the superiority of abdominal obesity measures in predicting metabolic risk [34].”
BackgroundAdipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 114
KUO, J.-J., Chang, H., Tsai, T., & Lee, T.-Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1049 · Cited by 102
“Obesity is associated with chronic inflammation, evidenced by increased levels of chemokines/cytokines in AT and liver and increased accumulation and activation of macrophages in AT and liver (1-3).”
Tinahones, F. J., Coín-Aragüez, L., Mayas, M. D., Garcia-Fuentes, E., Hurtado-del-Pozo, C., Vendrell, J., Cardona, F., Calvo, R.-M., Obregon, M.-J., & El Bekay, R. (2012) · BMC Physiology · doi:10.1186/1472-6793-12-4 · Cited by 95
“Obesity is very often accompanied by other diseases, the most common being type 2 diabetes mellitus (T2DM) and cardiovascular complications [1-3].”
BackgroundInfluentialAndrogens and Adipose Tissue in Males: A Complex and Reciprocal Interplay
Mammi, C., Calanchini, M., Antelmi, A., Cinti, F., Rosano, G. M. C., Lenzi, A., Caprio, M., & Fabbri, A. (2012) · International Journal of Endocrinology · doi:10.1155/2012/789653 · Cited by 95
“Excess visceral fat and related comorbidities define a condition named metabolic syndrome, characterized by hypertension, obesity, dyslipidemia, type 2 diabetes, and insulin resistance [60, 61].”
BackgroundIsaac, R., Boura-Halfon, S., Gurevitch, D., Shainskaya, A., Levkovitz, Y., & Zick, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408641 · Cited by 91
“Weight gain that leads to obesity is associated with an increased incidence of hypertension, dyslipidemia, coronary artery disease, insulin resistance, and overt diabetes (3, 7).”
BackgroundDynamical network biomarkers: Theory and applications
Aihara, K., Liu, R., Koizumi, K., Liu, X., & Chen, L. (2021) · Gene · doi:10.1016/j.gene.2021.145997 · Cited by 107
Obesity, visceral fat and Crohnʼs disease
Bertin, B., Desreumaux, P., & Dubuquoy, L. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833cf0f4 · Cited by 91
Fleischhacker, W. W., Siu, C. O., Bodén, R., Pappadopulos, E., Karayal, O. N., Kahn, R. S., & the EUFEST study group (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001241 · Cited by 89
“Monitoring change in WC and/or the waist :hip ratio has proven to be a simpler, more reliable and significant predictor of metabolic disorders and conversion to type 2 diabetes mellitus than calculated BMI (Stamler et al., 2000; Despres and Lemieus 2006; Mattsson et al., 2008).”
BackgroundMethodApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects
Sierra-Johnson, J., Romero-Corral, A., Somers, V. K., Lopez-Jimenez, F., Walldius, G., Hamsten, A., Hellenius, M.-L., & Fisher, R. M. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm360 · Cited by 96
Ma, J., McKeown, N. M., Hwang, S.-J., Hoffmann, U., Jacques, P. F., & Fox, C. S. (2016) · Circulation · doi:10.1161/circulationaha.115.018704 · Cited by 84
“370 Abdominal adipose tissue, particularly visceral adipose tissue (VAT), has been linked to the development of type 2 diabetes mellitus and cardiovascular disease.(1) Imaging techniques such as computed tomography (CT) can be exploited to assess the quantity of abdominal adipose tissue, including VAT and subcutaneous…”
BackgroundLiu, X., Kris‐Etherton, P. M., West, S. G., Lamarche, B., Jenkins, D. J. A., Fleming, J. A., McCrea, C. E., Pu, S., Couture, P., Connelly, P. W., et al. (2016) · Obesity · doi:10.1002/oby.21584 · Cited by 105
“Numerous studies have shown that android fat mass is positively correlated with BP, TG, and C-reactive protein levels (31-33).”
BackgroundMacLaren, R., Cui, W., Simard, S., & Cianflone, K. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700199-jlr200 · Cited by 95
“Many studies have focused on the physiologic parameters and genetic predisposition of subjects presenting with both obesity and insulin resistance (3).”
BackgroundMaitra, A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50029-8 · Cited by 105
Obesity and Mortality: Watch Your Waist, Not Just Your Weight
Hu, F. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.875 · Cited by 129
Zeng, X., Jedrychowski, M. P., Chen, Y., Serag, S., Lavery, G. G., Gygi, S. P., & Spiegelman, B. M. (2016) · Genes & Development · doi:10.1101/gad.285312.116 · Cited by 99
“…challenge to human health, as obese individuals are pre-disposed to multiple pathological conditions, such as cardiovascular diseases, type 2 diabetes, hypertension, and certain types of cancer (Després and Lemieux 2006; Gaal et al. 2006; Kahn et al. 2006; Basen-Engquist and Chang 2011).”
Miyazaki, Y., & DeFronzo, R. A. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-44 · Cited by 90
“With respect to relationship between visceral fat accumulation and hepatic insulin resistance (impaired insulininduced suppression of glucose production at liver), three scenarios have been proposed [34,40]: (i) altered release of adipocytokines into the portal vein by an expanded mass of visceral adipose tissue; (ii)…”
BackgroundElevated triglycerides/HDL-cholesterol ratio associated with insulin resistance.
González-Chávez, A., Simental‐Mendía, L. E., & Elizondo-Argueta, S. (2011) · PubMed · Cited by 114
DeBoer, M. D., Filipp, S. L., & Gurka, M. J. (2018) · Diabetes Care · doi:10.2337/dc18-1079 · Cited by 92
“This is not unexpected given the central role that visceral obesity plays in driving insulin resistance and the abnormalities associated with MetS (34).”
BackgroundSilvestri, C., Ligresti, A., & Marzo, V. D. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9167-3 · Cited by 92
“In view of: 1) the postulated protective role of subcutaneous fat as, among others, a buffer preventing ectopic fat deposition, 2) the strong association between abdominal-visceral fat with dyslipidemia, dyslipoproteinemia and insulin resistance [34]; and 3) the lipogenic action of CB1 receptors, the unbalance of the…”
BackgroundFottrell, E. F., Ahmed, N., Shaha, S. K., Jennings, H. M., Kuddus, A., Morrison, J., Akter, K., Nahar, B., Nahar, T., Haghparast‐Bidgoli, H., et al. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-000787 · Cited by 92
Redox implications in adipose tissue (dys)function-A new look at old acquaintances
Jankovic, A., Korac, A., Buzadzic, B., Otasevic, V., Stancic, A., Daiber, A., & Korac, B. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.018 · Cited by 91
“sues and resultant insulin resistance [150,151].”
Ding, Z., Wu, X. ‐., Remer, E. M., Lian, L., Stocchi, L., Li, Y., McCullough, A. J., Remzi, F. H., & Shen, B. (2015) · Colorectal Disease · doi:10.1111/codi.13128 · Cited by 91
Metadata
- Authors
- Després, J.-P., & Lemieux, I.
- Venue
- Nature
- Published
- 2006-12-13
- Volume
- 444
- Issue
- 7121
- Pages
- 881-887
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991334358
- Semantic Scholar
- 12903a24428f6c6024aed0c7b8de08306f8b15ff
- Cited by
- 4,354
- References
- 94
- Citations by year
- 2026: 146 · 2025: 172 · 2024: 216 · 2023: 209 · 2022: 259 · 2021: 259 · 2020: 223 · 2019: 231 · 2018: 236 · 2017: 225 · 2016: 265 · 2015: 236 · 2014: 270 · 2013: 269 · 2012: 241
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- abdominal obesity, metabolic syndrome, insulin resistance, diabetes risk, cardiovascular risk, inflammation, risk assessment algorithm, diagnostic criteria
- MeSH terms
- Abdomen, Cardiovascular Diseases, Humans, Obesity, Risk Assessment, Metabolic Syndrome, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.